Publications by authors named "Vlado Perkovic"

100Publications

An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials.

Int J Cardiol 2020 Sep 23. Epub 2020 Sep 23.

The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Australia; UNSW, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2020.09.050DOI Listing
September 2020

Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.

Am J Kidney Dis 2020 Sep 21. Epub 2020 Sep 21.

The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Centre for Nephrology, University College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2020.06.018DOI Listing
September 2020

The impact of the COVID-19 pandemic on medical education.

Med J Aust 2020 Sep 6. Epub 2020 Sep 6.

UNSW Sydney, Sydney, NSW.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja2.50762DOI Listing
September 2020

Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning.

J Card Fail 2020 Sep 3. Epub 2020 Sep 3.

The George Institute for Global Health and University of New South Wales, Sydney, Australia; Renal Unit, Concord Repatriation General Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2020.09.001DOI Listing
September 2020

Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.

J Am Soc Nephrol 2020 Jul 21. Epub 2020 Jul 21.

Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2019121312DOI Listing
July 2020

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.

Diabetes Obes Metab 2020 Jul 20. Epub 2020 Jul 20.

The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.14143DOI Listing
July 2020

The impact of the COVID-19 pandemic on medical education.

Med J Aust 2020 Jul 17. Epub 2020 Jul 17.

Office of Medical Education, UNSW, Sydney, NSW.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja2.50705DOI Listing
July 2020

Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Clin J Am Soc Nephrol 2020 Aug 16;15(8):1129-1138. Epub 2020 Jul 16.

The George Institute for Global Health, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.12201019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409758PMC
August 2020

Effects of Allopurinol on the Progression of Chronic Kidney Disease.

N Engl J Med 2020 06;382(26):2504-2513

From the Department of Renal Medicine, St. George Hospital (S.V.B., A.T.), the Renal and Metabolic Division, George Institute for Global Health (S.V.B., A.T., V.P.), and St. Vincent's Clinical School (R.O.D., G.R.D.J.), University of New South Wales Medicine, the Departments of Clinical Pharmacology and Toxicology (R.O.D.) and Chemical Pathology, SydPath (G.R.D.J.), St. Vincent's Hospital, the Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney (D.C.H., G.K.R.), the Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District (D.C.H., G.K.R.), and the Department of Nephrology, the Royal North Shore Hospital (V.P.), Sydney, the Australasian Kidney Trials Network, University of Queensland (S.V.B., E.M.P., N.B., C.M.H., D.R., L.R., D.W.J.), the Department of Nephrology, Princess Alexandra Hospital, (B.D., C.M.H., D.W.J.), and the Translational Research Institute (D.W.J.), Brisbane, QLD, the Medical School, University of Western Australia, Perth (N.B.), the Department of Nephrology, Monash University at Monash Medical Centre, Melbourne, VIC (F.G.B., J.K.), Menzies School of Health Research, Charles Darwin University, Darwin, NT (A.C.), the University of Adelaide and Central Northern Adelaide Renal and Transplantation Services, Adelaide, SA (R.F.), and the Australian National University Medical School and the Department of Nephrology, Canberra Hospital, Canberra, ACT (G.W.) - all in Australia; the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom (P.C.); and the Department of Medicine, University of Auckland (N.D., J.R.Z.), and the Renal Service, Waitemata District Health Board (J.R.Z.), Auckland, the Department of Medicine, University of Otago Christchurch, Christchurch (S.C.P.), and Dunedin School of Medicine, University of Otago, Dunedin (R.J.W.) - all in New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1915833DOI Listing
June 2020

No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial.

Nephrology (Carlton) 2020 Oct 2;25(10):792-800. Epub 2020 Jul 2.

Renal and Metabolic Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nep.13737DOI Listing
October 2020

Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes.

Kidney Int 2020 Sep 27;98(3):769-777. Epub 2020 May 27.

The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia; University of New South Wales, Sydney, Australia; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2020.04.051DOI Listing
September 2020

The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.

Diabetes Obes Metab 2020 May 21. Epub 2020 May 21.

Cardiovascular Division, The George Institute for Global Health, UNSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.14091DOI Listing
May 2020

Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis.

J Card Fail 2020 Jun 14;26(6):482-491. Epub 2020 Apr 14.

The George Institute for Global Health and University of New South Wales, Sydney, Australia; Renal Unit, Concord Repatriation General Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2020.03.010DOI Listing
June 2020

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?

Nephrol Dial Transplant 2020 01;35(Suppl 1):i48-i55

George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993192PMC
January 2020

Pilot Trials in Nephrology: Establishing a BASE for Large-Scale Randomized Trials.

J Am Soc Nephrol 2020 01 17;31(1):4-6. Epub 2019 Dec 17.

The George Institute for Global Health and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2019111196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934990PMC
January 2020

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review.

BMJ Glob Health 2019 12;4(6):e001940. Epub 2019 Nov 12.

Renal and Metabolic Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgh-2019-001940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861095PMC
November 2019

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.

JACC Heart Fail 2020 01 29;8(1):57-66. Epub 2019 Oct 29.

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia; Imperial College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.004DOI Listing
January 2020

Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

CMAJ 2019 Oct;191(41):E1128-E1135

The George Institute for Global Health (Neuen, Jardine, Perkovic), University of New South Wales, Sydney, Australia; Division of Nephrology (Cherney), Departments of Medicine and Physiology, University Health Network, University of Toronto, Toronto, Ont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.190047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791785PMC
October 2019

Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply.

N Engl J Med 2019 09;381(11):1089-1090

George Institute for Global Health, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1909687DOI Listing
September 2019

Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.

Nephrol Dial Transplant 2019 Sep 8. Epub 2019 Sep 8.

Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz179DOI Listing
September 2019

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.

Lancet Diabetes Endocrinol 2019 11 5;7(11):845-854. Epub 2019 Sep 5.

The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Concord Repatriation and General Hospital, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30256-6DOI Listing
November 2019

Blood pressure: at what level is treatment worthwhile?

Aust Prescr 2019 Aug 1;42(4):127-130. Epub 2019 Aug 1.

The George Institute for Global Health, UNSW Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698244PMC
August 2019

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.

Diabetologia 2019 10 10;62(10):1854-1867. Epub 2019 Aug 10.

The George Institute for Global Health, UNSW Sydney, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-019-4955-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731200PMC
October 2019

Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.

Ann Intern Med 2019 08 16;171(3):181-189. Epub 2019 Jul 16.

The George Institute for Global Health, UNSW Medicine, and St. George Hospital, Sydney, New South Wales, Australia (J.T.H., L.P.C., S.V.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M19-0087DOI Listing
August 2019

Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis.

JAMA Intern Med 2019 Jul 8. Epub 2019 Jul 8.

The George Institute for Global Health and University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2019.1501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618769PMC
July 2019

Is it time to REWIND the cardiorenal clock in diabetes?

Lancet 2019 07 9;394(10193):95-97. Epub 2019 Jun 9.

Department of Renal Medicine, Royal North Shore Hospital, St Leonards, NSW, Australia; Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31267-XDOI Listing
July 2019

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Clin J Am Soc Nephrol 2019 06 3;14(6):862-872. Epub 2019 Jun 3.

The George Institute for Global Health, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.13391118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556720PMC
June 2019

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2019 05;95(5):1027-1036

KfH Kidney Center, Munich, Germany; Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.12.025DOI Listing
May 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

N Engl J Med 2019 06 14;380(24):2295-2306. Epub 2019 Apr 14.

From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) - all in Australia; Imperial College London (B.N.) and the Department of Renal Medicine, UCL Medical School (D.C.W.) - both in London; the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H., D.Z.); the Nephrology Division, NYU School of Medicine and NYU Langone Medical Center, New York (D.M.C.); Baim Institute for Clinical Research (D.M.C., C.P.C., B.M.B.), the Cardiovascular Division (C.P.C.) and the Renal Division and Department of Medicine (B.M.B), Brigham and Women's Hospital, and Harvard Medical School (B.M.B.) - all in Boston; Janssen Research and Development, Raritan, NJ (R.E., S. Bull, G.C., P.-L.C., Y.Y., G.M.); Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis (R.A.); the Department of Medicine, University of Chicago Medicine, Chicago (G.B.); the Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City (T.G.); the Division of Nephrology, University of British Columbia, Vancouver (A.L.), and the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.) - all in Canada; the Renal Division, Peking University First Hospital, Beijing (H.Z.); and the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1811744
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1811744DOI Listing
June 2019

Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial.

CMAJ 2019 03;191(9):E247-E256

Division of Nephrology (Garg, Cuerden, Sontrop), Department of Medicine, London Health Sciences Centre, London, Ont.; Department of Anaesthesia and Intensive Care (Chan), The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Departments of Health Research Methods, Evidence, and Impact, and Medicine (Devereaux, Walsh), McMaster University, Hamilton, Ont.; Tehran Heart Center (Abbasi), Tehran University of Medical Sciences, Tehran, Iran; Division of Nephrology (Hildebrand), Department of Medicine, University of Alberta, Edmonton, Alta.; Département de médecine (Lamontagne), Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Que.; Department of Surgery (Lamy) McMaster University, Hamilton, Ont.; Department of Cardiac Surgery (Noiseux), Université de Montréal, Montréal, Que.; Division of Nephrology, Johns Hopkins School of Medicine (Parikh), Baltimore, Md.; The George Institute for Global Health (Perkovic), Sydney, Australia; Division of Cardiac Surgery (Quantz), London Health Sciences Centre, University Hospital, London, Ont.; Montreal Heart Institute (Rochon), Université de Montréal, Montréal, Que.; Department of Surgery (Royse), University of Melbourne, Melbourne, Australia; Department of Outcomes Research (Sessler), Cleveland Clinic, Cleveland, Ohio; Department of Cardiac Surgery (Shah), Princess Alexandra Hospital, Brisbane, Australia; Department of Cardiovascular and Thoracic Surgery (Tagarakis), Aristotle University of Thessaloniki, Thessaloniki, Greece; Division of Cardiac Surgery (Teoh), Southlake Regional Health Centre, Newmarket, Ont.; Population Health Research Institute (Vincent, Whitlock), Hamilton, Ont.; Department of Cardiothoracic Anesthesiology (Yared), Cleveland Clinic, Cleveland, Ohio; Division of Cardiology (Yusuf), Department of Medicine, McMaster University, Hamilton, Ont.

View Article

Download full-text PDF

Source
http://www.cmaj.ca/lookup/doi/10.1503/cmaj.181644
Publisher Site
http://dx.doi.org/10.1503/cmaj.181644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400656PMC
March 2019

Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial.

Nephrology (Carlton) 2019 Oct 29;24(10):1056-1063. Epub 2019 Apr 29.

The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nep.13530DOI Listing
October 2019

New hypoglycemic agents and the kidney: what do the major trials tell us?

F1000Res 2018 23;7. Epub 2018 Nov 23.

The George Institute for Global Health, UNSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.16135.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259591PMC
March 2019

Reducing cardiovascular risk in people with diabetes and kidney disease.

Med J Aust 2018 11;209(10):438-439

The George Institute for Global Health, Sydney, NSW.

View Article

Download full-text PDF

Source
November 2018

ACCORDION: Ensuring That We Hear the Music Clearly.

Clin J Am Soc Nephrol 2018 11 25;13(11):1621-1623. Epub 2018 Oct 25.

Division of Renal and Metabolic, The George Institute for Global Health, University of New South Wales, Sydney, Australia;

View Article

Download full-text PDF

Source
http://cjasn.asnjournals.org/lookup/doi/10.2215/CJN.11370918
Publisher Site
http://dx.doi.org/10.2215/CJN.11370918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237047PMC
November 2018

Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".

Circulation 2018 08;138(6):660-661

Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035717DOI Listing
August 2018

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.

Diabetes Obes Metab 2018 10;20 Suppl 3:14-18

George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13417
Publisher Site
http://dx.doi.org/10.1111/dom.13417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220936PMC
October 2018

Glucose lowering and the kidney: are all drug classes equal?

Lancet Diabetes Endocrinol 2018 11 3;6(11):835-837. Epub 2018 Oct 3.

The George Institute for Global Health, UNSW Sydney, Sydney, NSW 2042, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(18)30291-2DOI Listing
November 2018

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Cochrane Database Syst Rev 2018 Sep 24;9:CD011798. Epub 2018 Sep 24.

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD011798.pub2
Publisher Site
http://dx.doi.org/10.1002/14651858.CD011798.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513625PMC
September 2018

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.

Lancet Diabetes Endocrinol 2018 09 21;6(9):691-704. Epub 2018 Jun 21.

The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(18)30141-4DOI Listing
September 2018

Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease: Moving from Single Trials to an Ongoing Platform.

Clin J Am Soc Nephrol 2018 06 26;13(6):946-948. Epub 2018 Apr 26.

George Institute for Global Health, University of New South Wales Sydney, Newtown Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.01290118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989668PMC
June 2018

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review.

Diabetes Res Clin Pract 2018 Jun 28;140:118-128. Epub 2018 Mar 28.

The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Australia; The Charles Perkins Centre, University of Sydney, Australia; Division of Epidemiology and Biostatistics, Imperial College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2018.03.027DOI Listing
June 2018

Baseline characteristics and enrichment results from the SONAR trial.

Diabetes Obes Metab 2018 08 1;20(8):1829-1835. Epub 2018 May 1.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13315
Publisher Site
http://dx.doi.org/10.1111/dom.13315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055730PMC
August 2018

Effect of extended hours dialysis on sleep quality in a randomized trial.

Nephrology (Carlton) 2019 Apr;24(4):430-437

Renal & Metabolic Division, The George Institute for Global Health, UNSW, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/nep.13236
Publisher Site
http://dx.doi.org/10.1111/nep.13236DOI Listing
April 2019

Chronic kidney disease and the global NCDs agenda.

BMJ Glob Health 2017 6;2(2):e000380. Epub 2017 Jul 6.

Renal and Metabolic Division, George Institute for Global Health, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgh-2017-000380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717948PMC
July 2017

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

N Engl J Med 2017 11;377(21):2099

University of Oxford, Oxford, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1712572DOI Listing
November 2017

Action plan for optimizing the design of clinical trials in chronic kidney disease.

Kidney Int Suppl (2011) 2017 Oct 20;7(2):138-144. Epub 2017 Sep 20.

Department of Medicine, Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kisu.2017.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341012PMC
October 2017

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.

PLoS One 2017 12;12(9):e0184398. Epub 2017 Sep 12.

Renal Division and Institute of Nephrology, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184398PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595305PMC
October 2017

Are SGLT2 Inhibitors Ready for Prime Time for CKD?

Clin J Am Soc Nephrol 2018 02 11;13(2):318-320. Epub 2017 Sep 11.

George Institute for Global Health, Newtown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.07680717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967433PMC
February 2018

Renal trials in diabetes need a platform: time for a global approach?

Lancet Diabetes Endocrinol 2018 05 7;6(5):356-358. Epub 2017 Aug 7.

George Institute, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30263-2DOI Listing
May 2018

Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST).

N Engl J Med 2017 07;377(3):298-300

George Institute for Global Health, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1703337DOI Listing
July 2017

Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis.

JAMA 2017 Jul;318(2):156-166

The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia7The Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia8Division of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2017.7967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541330PMC
July 2017